CHRISTINA ARNOLD: Open Payments
NPI 1114918901 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,920 in 157 payments from 19 companies in 2025. Trend: 2023 $4,282 · 2024 $4,445 · 2025 $8,920
Food & beverage: $3,862Consulting: $3,365Travel & lodging: $1,693
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $5,754 |
| ABBVIE INC. | 38 | $1,032 |
| Amgen Inc. | 23 | $349 |
| GENZYME CORPORATION | 2 | $274 |
| Lilly USA, LLC | 11 | $272 |
| AstraZeneca Pharmaceuticals LP | 8 | $214 |
| Mallinckrodt Hospital Products Inc. | 8 | $190 |
| Janssen Biotech, Inc. | 7 | $167 |
| PFIZER INC. | 10 | $164 |
| UCB, Inc. | 5 | $113 |
Products named: COSENTYX, RINVOQ, SKYRIZI, KEVZARA, TALTZ, SAPHNELO, ACTHAR, XELJANZ.
Industry payments across FL — which companies pay providers there.
